Lostam BioPharmaceuticals Overview

  • Founded
  • 2009

Founded
  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Lostam BioPharmaceuticals General Information

Description

Developer of protein therapeutics designed to prevent and treat lethal Gram-negative bacterial infections. The company's protein therapeutics offers a panel of human therapeutic protein candidates and novel pipelines of anti-bacterial drugs capable of combating serious bacterial infections and of withstanding the cunning efforts of bacteria to develop drug-resistant mechanisms, enabling doctors to treat and prevent lethal Gram-negative bacterial infections associated primarily within the hospital setting.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Nazareth Industrial Area
  • PO Box 2252
  • Nazareth 16000
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lostam BioPharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Jul-2017 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view Lostam BioPharmaceuticals’s complete valuation and funding history, request access »

Lostam BioPharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of protein therapeutics designed to prevent and treat lethal Gram-negative bacterial infections. The company's
Biotechnology
Nazareth, Israel
00000000 00

000000

mmodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fug
0000 000000000
Barcelona, Spain
00 As of 0000
0000
000000000000 0000

000 00

m veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis au
0000 000000000
Barcelona, Spain
00 As of 0000
0000
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lostam BioPharmaceuticals Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ability Pharma Venture Capital-Backed Barcelona, Spain 00 0000 000000000000 0000
000 000000000000 Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
000000000 000000 Venture Capital-Backed Boston, MA 00 00000 0000000000 0 00000
00000000 Venture Capital-Backed Boston, MA 00 0000 00000000000 0000
0000000 Venture Capital-Backed Solna, Sweden 0 00.000 0000000000 00.000
You’re viewing 5 of 8 competitors. Get the full list »

Lostam BioPharmaceuticals Patents

Lostam BioPharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20130096282-A1 Therapeutic antibodies against flagellated pseudomonas aeruginosa Granted 01-Mar-2010 00000000000 0
US-8653242-B2 Therapeutic antibodies against flagellated pseudomonas aeruginosa Expired - Fee Related 01-Mar-2010 00000000000 0
EP-2542577-A1 Improved therapeutic antibodies against flagellated pseudomonas aeruginosa Withdrawn 01-Mar-2010 C07K16/1214

Lostam BioPharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Lewis Neville Ph.D Founder, Chief Technology Officer & Chief Executive Officer
To view Lostam BioPharmaceuticals’s complete executive team members history, request access »